tm logo
PARSABIV
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 09 Aug 2024

Last Applicant/ Owned by

One Amgen Center Drive

Thousand Oaks

CA

91320-1799

Serial Number

87038725 filed on 16th May 2016

Registration Number

5438851 registered on 03rd Apr 2018

in the Principal Register

Correspondent Address

Elsa D. Lemoine

Elsa D. Lemoine Amgen Inc.

Trademark Operations MS-28-5-A

Thousand Oaks, CA 91320-1799

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

PARSABIV

Pharmaceutical preparations used for the treatment of parathyroid, glandular and hormone disorders; pharmaceutical preparations used for the treatment of renal and kidney disorders

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations used for the treatment of parathyroid, glandular and hormone disorders; pharmaceutical preparations used for the treatment of renal and kidney disorders


First Use Date in General

03rd Jan 2018

First Use Date in Commerce

03rd Jan 2018

Mark Details


Serial Number

No 87038725

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TM-1475-US-1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
09th Aug 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09th Aug 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09th Aug 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
24th Jan 2024TEAS SECTION 8 & 15 RECEIVED
03rd Apr 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07th Mar 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07th Mar 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03rd Apr 2018REGISTERED-PRINCIPAL REGISTER
24th Feb 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
23rd Feb 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED